Evidence map›Paper›PMID 33389535›Full record

ReviewMolecular biology reports2021

A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.

Shehwaz Anwar, Shifa Khan, Ahmad Almatroudi, Amjad Ali Khan, Mohammed A Alsahli, Saleh A Almatroodi, Arshad Husain Rahmani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 141 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecules (Basel, Switzerland) · 2026
    Article
  9. Antioxidants (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Nutrients · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Indole metabolism and its role in diabetic macrovascular and microvascular complications.American heart journal plus : cardiology research and practice · 2025
    Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shehwaz AnwarDepartment of Medical Laboratories, College of Applied Medical Science, Qassim University, Buraydah, 52571, Saudi Arabia.
Shifa KhanDepartment of Biochemistry, Faculty of Medicine, JNMC, Aligarh Muslim University, Aligarh, Uttar Pradesh, 202002, India.
Ahmad AlmatroudiDepartment of Medical Laboratories, College of Applied Medical Science, Qassim University, Buraydah, 52571, Saudi Arabia.
Amjad Ali KhanDepartment of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, P.O. Box 6699, Buraydah, 51452, Saudi Arabia.
Mohammed A AlsahliDepartment of Medical Laboratories, College of Applied Medical Science, Qassim University, Buraydah, 52571, Saudi Arabia.
Saleh A AlmatroodiDepartment of Medical Laboratories, College of Applied Medical Science, Qassim University, Buraydah, 52571, Saudi Arabia.
Arshad Husain RahmaniDepartment of Medical Laboratories, College of Applied Medical Science, Qassim University, Buraydah, 52571, Saudi Arabia. ah.rahmani@qu.edu.sa.
Qassim University · SAAligarh Muslim University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced glycation end products (AGEs) are naturally occurring biomolecules formed by interaction of reducing sugars with biomolecules such as protein and lipids etc., Long term high blood sugar level and glycation accelerate the formation of AGEs. Unchecked continuous formation and accumulation of AGEs are potential risks for pathogenesis of various chronic diseases. Current mode of antidiabetic therapy is based on synthetic drugs that are often linked with severe adverse effects. Polyphenolic compounds derived from plants are supposed to inhibit glycation and formation of AGEs at multiple levels. Some polyphenolic compounds regulate the blood glucose metabolism by amplification of cell insulin resistance and activation of insulin like growth factor binding protein signaling pathway. Their antioxidant nature and metal chelating activity, ability to trap intermediate dicarbonyl compounds could be possible mechanisms against glycation and AGEs formation and hence, against AGEs induced health complications. Although, few species of polyphenolic compounds are being used in in vitro trials and their in vivo study is still in progress, increasing the area of research in this field may produce a fruitful approach in management of overall diabetic complications.

Indexed as

AntioxidantsBlood GlucoseDiabetes MellitusGene Expression RegulationGlycation End Products, AdvancedGlycosylationHumansHypoglycemic AgentsInsulin-Like Growth Factor Binding Protein 1Insulin ResistanceObesityPhytochemicalsPolyphenolsSignal TransductionAntioxidantsBlood GlucoseGlycation End Products, AdvancedHypoglycemic AgentsIGFBP1 protein, humanInsulin-Like Growth Factor Binding Protein 1PhytochemicalsPolyphenolsAGEsAGEs inhibitorsAnti-AGEs strategiesAntiglycating mechanismPolyphenolic compounds

Identifiers

PMID33389535
OpenAlexW3119149752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.